Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Apr 1;11(2):96-101.

Inhibition of Angiogenesis: A Novel Effect of Zataria Multiflora

Affiliations

Inhibition of Angiogenesis: A Novel Effect of Zataria Multiflora

Amir Hossein Norooznezhad et al. Int J Hematol Oncol Stem Cell Res. .

Abstract

Background: Angiogenesis, the formation of new blood vessels from preexisting ones, is among the most important physiological and pathological processes that occur in the body. Under pathological conditions such as tumor growth, psoriasis, corneal neovascularization and rheumatoid arthritis, angiogenesis is substantial for the development of the disease. Zataria multiflora is a member of the Labiatae family with a vast range of traditional uses which has been long known and applied in Iran old medicine. The aim of this study was the evaluation of anti-angiogenic potential of Zataria multiflora. Materials and Methods: In this study, human umbilical vein endothelial cells (HUVECs) were isolated from newborn umbilical veins and then cultured for cytotoxicity (LDH test) assay. Regarding LDH results, following tests such as angiogenesis (cytodex-3 micro carrier) and migration (wound healing) tests were designed. Results: The cytotoxicity assays showed no toxicity of Z.multiflora toward HUVECs in the range of 10-450µg/mL of the extract. This extract was also able to inhibit angiogenesis and migration at 200µg/mL. Conclusion: Our data clearly demonstrated an inhibitory effect of Z. multiflora on angiogenesis and migration of HUVECs. Z. multiflora could be introduced as a significant angiogenesis inhibitor for angiogenesis-dependent diseases in further complementary studies.

Keywords: Angiogenesis; Cell migration; Endothelial cells; Zataria multiflora.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Evaluation of cytotoxic activity of extract on HUVECs using LDH and trypan blue assay
Figure 2
Figure 2
Cytodex 3- microcarriers in collagen gel A: Control. B: 200µg/mL of extract which completely prevented angiogenesis.
Figure 3
Figure 3
Inhibition of angiogenesis by Zataria M extract
Figure 4
Figure 4
Migration assay of HUVECs using wound healing model. A) HUVECs right after wound formation, B) Control after 24 h, wounded cell monolayers of HUVEC completely filled in the cleared area, C) 200µg/mL of extract which completely inhibited migration of HUVECs.
Figure 5
Figure 5
Inhibition of HUVECs’ migration at 200 µg/mL motility was significantly hindered.
Figure 6
Figure 6
Inhibition of HUVECs proliferation by Zataria M extract

Similar articles

Cited by

References

    1. Mostafaie A, Mohammadi-Motlagh HR, Mansouri K. Angiogenesis and the models to study angiogenesis. Yakhteh Med J. 2010;11:374–381.
    1. Norooznezhad AH, Norooznezhad F. How Could Cannabinoids Be Effective in Multiple Evanescent White Dot Syndrome? A Hypothesis. J Rep Pharm Sci. 2016;5:49–52.
    1. Shakiba Y, Mansouri K, Arshadi D, et al. Corneal neovascularization: molecular events and therapeutic options. Recent Pat Inflamm Allergy Drug Discov. 2009;3(3):221–231. - PubMed
    1. Heidenreich R, Röcken M, Ghoreschi K. Angiogenesis: the new potential target for treatment of psoriasis? Drug News Perspect. 2008;21(2):97–105. - PubMed
    1. Szekanecz Z, Koch AE. Angiogenesis and its targeting in rheumatoid arthritis. Vascul Pharmacol. 2009;51(1):1–7. - PMC - PubMed

LinkOut - more resources